NEWS ARCHIVE

Category: Feature 3

We’re extremely excited to announce the launch of our second Regulation A+ equity crowdfunding campaign. Due to popular demand, we have re-opened the opportunity to invest in BIOLIFE4D’s life-saving technology! Since our first equity crowdfunding campaign, we’ve made exceptional progress – including the successful demonstration of 3D bioprinting human tissue, along with heart components like chambers,…

Company names Dr. Michael Davidson, Mr. Stephen Simes, Dr. Mark Weinberg, and Mr. Bruce Werner as strategic advisors CHICAGO – January 28, 2019 – BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it has established a Management Advisory Board to offer strategy and leadership…

The last several months have been an incredible time for BIOLIFE4D. In February, we launched our equity crowdfunding campaign to help in our mission to 3D bioprint viable treatment alternatives to cardiac issues, like patches, valves, and full hearts for transplant. Our scientific achievements are progressing rapidly, and the media has certainly taken notice. We have…

Imagine a world where heart transplants do not cost that much and do not have long waiting lists. Imagine not having to go through immunosuppressive therapy following a life and death surgery. Fortunately, we won’t have to imagine these soon as BIOLIFE4D is already developing a technology that could eliminate these concerns and do more…

Build a Heart. Save a life.

Scroll Up